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Introduction
Patients with Parkinson’s disease are usually treated with 
dopaminergic medication. To cope with motor control 
problems many patients are also treated by a physiotherapist, 
even in early stages of the disease. The therapy is targeted 
at improving, maintaining, or delaying problems with gait, 
transfers, posture, balance, and general physical condition 
(Kwakkel et al 2007). Cognitive deﬁcits (eg, problems 
concentrating, attention problems) are also common in 
patients with Parkinson’s disease (Hoehn and Yahr 1967, 
Sammer et al 2006). Physiotherapy helps to improve, 
maintain, or delay problems with motor control (Dibble et 
al 2009, Kwakkel et al 2007). It has been hypothesised that 
movement imagery might have additional value in patients 
with Parkinson’s disease because it targets the conscious 
control of movement through cognitive strategies, which is 
generally recommended in national guidelines (Keus et al 
2004).
Athletes have used all sorts of cognitive skills to improve 
motor performance and the use of mental practice in athletes 
has been the subject of research for several decades (Feltz 
and Landers 1988). Recently mental practice has been used 
in different patient populations as an additional therapy 
(Dickstein and Deutsch 2007), on the understanding that 
it increases practice of skilled movements. Mental practice 
is generally described as repeated mental simulation of the 
execution of a target movement in the absence of bodily 
activity for the purpose of improving a given movement. 
This movement imagery technique can be described to 
patients as imagining oneself undertaking the skilled 
movement without actually doing the movement.
Brain imaging research in healthy subjects has shown 
that during vivid imagery of a speciﬁc movement almost 
the same brain areas are active as during overt movement 
(Milton et al 2008). Fundamental research in patients 
has mainly been done with patients suffering from stroke 
(Sharma et al 2006) and this kind of research with patients 
with Parkinson’s disease shows that some but not all are 
able to perform mental imagery (Cunnington et al 2001, 
Frak et al 2004).
Clinical studies of mental practice have been performed 
in various patient populations. There is some evidence 
that mental practice might help patients with conditions 
such as chronic pain, cancer, and orthopaedic pathologies 
(Dickstein and Deutsch 2007). However, the majority of 
clinical research has been performed in stroke patients 
(Braun et al 2006). Initially the focus of mental practice 
was on the improvement of arm-hand functions, but recently 
more studies have been performed to assess possible effects 
on locomotor tasks (Malouin and Richards 2009). There is 
also some evidence that several different mental practice 
interventions might work. It seems important, however, to 
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tailor the content of the mental practice to the abilities of 
the patient, as neurological conditions can inﬂuence the 
ability of patients to generate vivid images (cognitive level), 
decrease kinesthetic input, and limit physical performance 
(Braun et al 2008).
Only a few clinical studies have been conducted in patients 
with Parkinson’s disease (Tamir et al 2007, Yaguez et al 
1999) and results show some controversy on what effects 
a mental practice intervention might have. Mental practice 
should have the greatest effects on the movement that is 
actually mentally rehearsed (Feltz and Landers 1988). 
Recently, however, promising results on mobility tasks in 
a randomised clinical trial of reasonable size and duration 
have been published (Tamir et al 2007). It seems that mental 
practice might have a positive effect, but more research is 
needed to determine the effects with more certainty. We 
therefore performed a randomised controlled trial of a 
mental practice framework that is tailored to the patients’ 
abilities, in which patients with a wide range of disease 
severity were eligible. In this study, relaxation was treated 
as a sham intervention and only used to control for attention. 
Therefore the research questions for this study were:
1. Is mental practice embedded in physiotherapy 
according to the National Dutch guidelines compared 
with relaxation embedded in the same physiotherapy 
more effective at improving mobility in people with 
Parkinson’s disease in the community?
2. Does disease severity inﬂuence the treatment effect?
Method
Design
A multicentre randomised controlled trial was conducted 
over a one-year period. Participants were recruited from 
one of ﬁve locations at which they were receiving treatment: 
three community practices, and rehabilitation day treatment 
in a nursing home and hospital. All were outpatients.
Randomisation for all sites was conducted by an 
independent third party who was blinded to the potential 
participant’s characteristics. The randomisation schedule 
consisted of a random allocation list for each site. Each 
list had block sizes of four (Altman et al 2001). No other 
stratiﬁcation took place. After baseline measurement, the 
therapists were notiﬁed to which group the participant 
was assigned. The participants were not blinded to the 
treatment they were allocated because they were aware of 
the content of the treatment they received. Therapists were 
not blinded because they taught the participant the imagery 
or relaxation techniques.
Participants
People entering the trial had to meet the following inclusion 
criteria: clinically diagnosed adults with Parkinson’s 
disease, and sufﬁcient cognitive level and communication 
skills to engage in mental practice. The latter was 
determined by taking into account the clinical judgment 
of the treating therapist, support from family and the score 
on the Mini-Mental State Examination (Tombaugh and 
McIntyre 1992). Patients who had other conditions such as 
stroke, rheumatic diseases, or dementia prior to the onset 
of Parkinson’s disease and sufﬁcient to cause persistent 
premorbid disability were excluded.
At baseline, the following participant characteristics were 
recorded: age, gender, time since diagnosis of Parkinson’s 
disease, cognitive level assessed with the Mini-Mental State 
Examination (Tombaugh and McIntyre 1992), Hoehn and 
Yahr stage (Hoehn and Yahr 1967), and the use of walking 
aids.
Intervention
The participants recruited were already receiving 
physiotherapy according to the Dutch guidelines for 
patients with Parkinson’s disease (Keus et al 2004), some 
on a one-to-one basis and some in groups. This pre-existing 
treatment was continued. The randomly allocated ‘new’ 
treatment was incorporated into the participant’s program. 
All participants received six weeks of physiotherapy, leaving 
their own therapy frequency and organisation unchanged. 
Participants received either one hour of physiotherapy per 
week (groups) or two sessions of half an hour per week 
(individuals). Thus, in both cases, participants continued 
to receive six hours and did not increase their contact 
time with the therapist. If participants were treated on an 
individual basis for half an hour, 10 minutes were spent 
on mental practice or relaxation. In group sessions of one 
hour, the time was increased to 20 minutes. Therapy with 
the therapist was recorded in pre-structured ﬁles, which 
detailed content and duration. As soon as the therapists 
thought participants were able to perform imagery or 
relaxation outside of therapy they encouraged unguided 
mental practice. Logs (one per week) were handed to the 
participants to record unguided mental practice behaviour. 
In principle, a maximum of six logs could be completed.
Component Week
1 2 3 4 5 6
Explanation of the concept
Development of mental imagery 
techniques
Supervised mental imagery with 
practice at home
Consolidation
'JHVSF Overview of the components of the 6-week mental practice training.
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The main goal of the mental practice intervention was to 
improve locomotor tasks like walking, standing up from 
a chair or the ﬂoor. Therapists were trained to teach and 
monitor mental practice according to the framework in 
which four steps are distinguished: explaining the concept, 
developing imagery techniques, applying mental practice, 
and consolidating (Braun et al 2008). Figure 1 presents the 
time frame over which these four stages were utilised.
Unlike a ﬁxed treatment regimen, the mental imagery 
framework allowed the physiotherapist to tailor the content 
to each participant’s abilities and preferences. Examples 
of tailoring are the chosen view and the ratio of actual to 
imagined attempts at movements. Participants were told 
that imagery inherently involved a point of view. They 
were advised to try ﬁrst person (as if looking through their 
own eyes) and third person (as if looking at oneself from 
a distance), and were then allowed to choose whichever 
view they preferred (Milton et al 2008). During therapy, 
imagery attempts and overt movements were combined, 
ie, movements were performed to generate sensory 
information. This information was then embedded in the 
imagery attempts to make them as vivid as possible. The 
proportions of actual movements and imagery attempts 
were based on individual preferences (Malouin et al 2004). 
The ratio of actual to imagined attempts could change over 
time or differ depending on the task or its difﬁculty. The 
success of a participant in imagining the actions correctly 
and vividly was judged by the therapist in several ways: 
self-report by the participant, comparing the time taken 
to perform a task mentally against the time in reality, and 
by checking that the participant could recite the order of 
actions correctly.
The control therapy was used to control for attention and 
consisted of treatment according to the national Dutch 
guidelines (Keus et al 2004) with relaxation therapy being 
incorporated into each session. The amount of relaxation 
incorporated matched the amount of mental practice in 
the experimental group. Relaxation was chosen to enable 
comparison with the trial by Tamir and colleagues and 
followed the principles of progressive muscle relaxation 
according to Jacobson (Gessel 1989). Participants were 
encouraged to do relaxation homework outside of therapy 
as well, using unguided progressive muscle relaxation or by 
listening to a relaxation CD.
Outcome measures
Improvement in walking was assessed with a visual 
analogue scale (Donnelly and Carswell 2002, Stratford et al 
1995, Wewers and Lowe 1990). Participants and therapists 
were asked to score on a scale from 0 to 10 how well they 
thought the participant walked with 0 being ‘poor’ and 10 
being ‘excellent’.
Data from two measures from the Dutch guidelines were 
used: the Timed Up and Go test and the 10 m Walk test. The 
Timed Up and Go test measures the time a person needs 
to stand up from a chair, walk 3 m at a comfortable speed, 
turn around, walk back, and sit down. The test is internally 
consistent, reliable, valid, and responsive (Lin et al 2004, 
Mathias et al 1986, Morris et al 2001). The 10 m Walk test 
can be used in people able to walk independently with or 
without walking aids and/or orthoses. The test is reliable, 
valid and responsive (Garraway et al 1980).
The data on outcome measures were collected by an 
independent, blinded assessor. Data were collected at 
three assessment points: at baseline, after the 6-week 
intervention period, and at a follow-up assessment 3 months 
after randomisation. In order to reduce the inﬂuence of 
ﬂuctuating performance associated with the on/off periods 
that characterise Parkinson’s disease, data were collected 
on three separate days for each of the three assessment 
points and on each day each test was performed three times. 
At each assessment point, the three days of data collection 
were scheduled within a 2-week period: during the two 
weeks before the intervention started (Week –1 to 0), after 
the intervention period (Week 7–8) and at the follow-up 
assessment (Week 12–13). For each patient we used the 
mean score on each measure for the measurement period. 
Potentially this was the mean of nine values although some 
patients completed fewer measures. The visual analogue 
scale was measured only once in each assessment period.
Data analysis
The calculation of the sample size was based on the 
visual analogue scale outcome. We sought a difference 
between the two groups of 2 cm on the 0 to 10 cm visual 
analogue scale. In this sample size calculation, we used 
a standard deviation of 2.25 cm and assumed a 50:50 
random allocation. There is no literature available on the 
minimum clinically important difference between groups 
or the standard deviation in a population with Parkinson’s 
disease. In pain patients, however, the minimum clinically 
important change is set at 1.5 cm (Ostelo et al 2008). Since 
we hypothesised that participants in the control group 
would not improve we aimed for a 2-cm difference between 
groups. In other populations the standard deviation on a 
visual analogue scale is somewhere between 1.5 and 3.0 
(Donnelly and Carswell 2002). With the power of this study 
set at 90% and the level of signiﬁcance set at 5%, 19 patients 
in each group were needed to identify a 2-cm difference 
between groups as statistically signiﬁcant.
Group characteristics at baseline were presented using 
descriptive statistics: means and standard deviations for 
continuous variables, and absolute numbers of participants 
and percentages for categorical variables. Differences 
between groups with regard to baseline characteristics were 
judged on clinical relevance (Assmann et al 2000).
To account for the dependency of the observations in time 
generalised estimating equations, a longitudinal linear 
regression technique, were used to analyse the treatment 
effects at the end of the intervention and at follow-up. 
Generalised estimating equations were used because of the 
dependency of observations across time within participants 
and because the time frames between the baseline and post-
intervention and between post-intervention and follow-
up were not equal. As the level 1 variable we used the 
PARTICIPANT and as the level 2 variable we used TIME.
For the outcome measures, we report percentage change 
scores, to correct for differences between groups at 
baseline on outcome measures. As independent variables 
we included TIME, INTERVENTION and the interaction 
TIME × INTERVENTION. Mean difference in difference 
of percentage change scores was estimated by the model and 
the conﬁdence interval (95% CI) given. Normal distribution 
of the data on the calculated change scores of the outcome 
measures was checked visually (Q-Q Plot).
Braun et al: Mental practice in Parkinson’s disease
Journal of Physiotherapy 2011  Vol. 57  –   © Australian Physiotherapy Association 201130
Research
Three analyses with generalised estimating equations were 
conducted. The primary analysis of the effect of intervention 
was performed on the entire research population on 
an intention-to-treat basis. The second analysis was a 
per-protocol analysis; from the entire population, only 
participants who received 60% of the guided therapy (and 
reached at least Step 2 of the mental practice framework) 
and had practised unguided were included. The third 
analysis was a subgroup analysis of the initial population, 
performed on participants with a Hoehn and Yahr stage 
below 3, who were hypothesised to be more able to perform 
mental practice (Sammer et al 2006).
5BCMF Characteristics of participants.
Characteristic Participants
All participants 
(n = 47)
Participants with Hoehn and 
Yahr stage < 3 
(n = 36)
Exp 
(n = 25)
Con 
(n = 22)
Exp 
(n = 19)
Con 
(n = 17)
Gender, n male (%) 17 (68) 15 (68) 12 (63) 11 (65)
Age (yr), mean (SD) 70 (8) 69 (8) 69 (8) 68 (8)
Time since diagnosis (yr), mean (SD) 5.2 (5.0) 6.6 (7.8) 4.6 (4.1) 5.0 (7.1)
MMSE (yr), mean (SD) 27 (3) 27 (2) 28 (3) 27 (2)
Treated individually, n (%) 12 (48) 12 (55) 11 (58) 10 (59)
Treated in a group, n (%) 13 (52) 10 (45) 8 (42) 7 (41)
Hoehn and Yahr stage, n (%)
 1 6 (24) 3 (14) 6 (32) 3 (18)
 1–2 1 (4) 5 (23) 1 (5) 5 (29)
 2 8 (32) 6 (27) 8 (42) 6 (35)
 2–3 4 (16) 3 (14) 4 (21) 3 (18)
 3 3 (12) 4 (18) 0 (0) 0 (0)
 3–4 0 (0) 0 (0) 0 (0) 0 (0)
 4 3 (12) 1 (4) 0 (0) 0 (0)
Walking aid, n (%)
 none 22 (88) 19 (86) 18 (95) 16 (94)
 cane 2 (8) 2 (9) 1 (5) 1 (6)
 rollator 1 (4) 1 (5) 0 (0) 0 (0)
Exp = experimental group, Con = control group, MMSE = mini-mental state examination
Results
'MPXPGQBSUJDJQBOUTUISPVHIUIFUSJBM
Forty-seven participants were recruited to the study between 
February and April 2009. The baseline characteristics of 
the participants, and the characteristics of those included 
in the subgroup analysis (Hoehn and Yahr stage < 3), are 
presented in Table 1. Three participants in the experimental 
group and four in the control group withdrew from the 
study before the Week 7–8 assessment, with a further four 
experimental and three control group participants lost 
before the Week 12–13 assessment. The ﬂow of participants 
through the trial and the reasons for loss to follow-up are 
presented in Figure 2.
$PNQMJBODFXJUIUIFUSJBMNFUIPE
The amount of treatment received and compliance with the 
experimental and control interventions are summarised in 
Table 2. Data provided by the participants in their treatment 
logs conﬁrmed that therapists delivered the appropriate 
therapy in each case. Only two of the withdrawals appeared 
to be directly related to the intervention. One participant 
stopped because of the intervention (too much effort), and 
another stopped because she found thinking about motor 
actions was too confronting.
Table 3 shows the results from the intention-to-treat 
analysis, while individual data are presented in Table 4 
(see eAddenda for Table 4). No signiﬁcant differences were 
found between the two groups on any outcome measure at 
any point.
5BCMFMean (SD) of the amounts of physiotherapist 
contact and independent practice of the allocated 
intervention and the average duration of independent 
practice per session.
Therapy
Groups
Exp Con
Supervised physiotherapy
 Treatments (number/participant) 7.7 (3.5) 7.7 (3.4)
 Duration (hr) 5.2 (1.3) 5.3 (1.1)
Independent practice
 Sessions (number/participant) 55 (53) 22 (44)
 Total duration (min) 271 (257) 268 (449)
 Duration per session (min) 5 12
SD = standard deviation
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Lost to follow-up (n = 3)
 hospitalised with 
relapse (n = 2)
 too confronting (n = 1)
Experimental Group
 physiotherapy 
 mental practice
 usual care
Control Group
 physiotherapy
 relaxation
 usual care
Lost to follow-up (n = 4)
 hospitalised with 
relapse (n = 3)
 died (n = 1)
Week –1 to 0
Lost to follow-up (n = 3)
 illness (n = 1)
 fall (n = 1)
 relapse (n = 1)
Lost to follow-up (n = 4)
 too much effort (n = 2)
 additional diagnosis 
(n = 2)
Measured walking ability as rated by therapist and participant on a VAS, Timed Up and  
Go test, 10 m walk time 
(n = 18)                                                                              (n = 15)
Week 12 to 13
Measured walking ability as rated by therapist and participant on a VAS, Timed Up and  
Go test, 10 m walk time 
Randomised (n = 47)
(n = 25)                                                                              (n = 22)
Excluded (n = 12)
 ineligible (n = 5)
 refused (n = 7)
Patients assessed for eligibility (n = 59)
 Centre 1 (n = 16)
 Centre 2 (n = 15)
 Centre 3 (n = 8)
 Centre 4 (n = 8)
 Centre 5 (n = 12)
Week 7 to 8
Measured walking ability as rated by therapist and participant on a VAS, Timed Up and  
Go test, 10 m walk time 
(n = 22)                                                                              (n = 18)
'JHVSFDesign and ﬂow of participants through the trial. VAS = visual analogue scale
For the per-protocol analysis, seven participants from the 
experimental group and ﬁve from the control group were 
excluded from the entire research population. In ten of these 
twelve participants the treatment amount was insufﬁcient 
(below 60%). One participant from the experimental group 
was excluded because he used mental practice to relax and 
one because he did not reach Stage 2 of the mental practice 
framework. The results were similar to the intention-to-
treat analysis (data not shown).
For the subgroup analyses, from the entire research 
population six participants in the mental practice group 
and ﬁve in the control group were excluded because they 
were Stage 3 or higher on the Hoehn and Yahr classiﬁcation 
(see Table 1). Table 5 presents the results of the subgroup 
analysis. No signiﬁcant differences were found between 
the two groups on any outcome measure at any point. 
However, except for the results of the difference score of the 
Timed Up and Go test at follow-up, all measures showed 
more average improvement compared with baseline for the 
mental practice group at both measurement points. These 
differences were not signiﬁcant.
Braun et al: Mental practice in Parkinson’s disease
Journal of Physiotherapy 2011  Vol. 57  –   © Australian Physiotherapy Association 201132
Research
5B
CM
F

M
e
a
n
 (S
D)
 of
 gr
o
u
ps
,
 
pe
rc
e
n
ta
ge
 c
ha
n
ge
 (S
D)
 fro
m
 b
a
se
lin
e,
 
a
n
d 
m
e
a
n
 (9
5%
 C
I) d
iff
e
re
n
ce
 b
e
tw
e
e
n
 g
ro
u
ps
 in
 p
e
rc
e
n
ta
ge
 c
ha
n
ge
 fr
o
m
 b
a
se
lin
e
 fo
r a
ll 
ou
tc
o
m
e
s,
 
fo
r a
ll 
pa
tie
nt
s 
(in
te
n
tio
n-
to
-
tre
at
 
a
n
a
lys
is)
.
 
G
en
er
al
ise
d 
e
st
im
at
in
g 
e
qu
at
io
ns
 
(G
EE
) w
e
re
 
u
se
d 
to
 
e
st
im
at
e
 
ch
a
n
ge
s 
in
 
sc
o
re
s 
fro
m
 
ba
se
lin
e
 b
e
tw
e
e
n
 s
u
bje
ct
s 
a
n
d 
ov
e
r 
tim
e
 
a
s 
a
 d
iff
e
re
n
ce
 
in
 
di
ffe
re
n
ce
 
sc
o
re
 
in
 
pe
rc
e
n
t.
O
u
tc
o
m
e
G
ro
u
ps
Pe
rc
e
n
ta
ge
 c
ha
n
ge
 fr
o
m
 b
a
se
lin
e
 (S
D)
,
 
e
st
im
a
te
d 
fro
m
 G
EE
D
iff
e
re
n
ce
 
in
 
pe
rc
e
n
ta
ge
 
ch
a
n
ge
 
fro
m
 b
a
se
lin
e
 b
e
tw
e
e
n
 g
ro
u
ps
 
(95
%
 C
I), 
e
st
im
a
te
d 
fro
m
 G
EE
 
W
e
e
k 
–1
 to
 0
W
e
e
k 
7 
to
 8
W
e
e
k 
12
 to
 1
3
W
e
e
k 
7 
to
 8
 
W
e
e
k 
12
 to
 1
3
W
e
e
k 
7 
to
 8
 
W
e
e
k 
12
 to
 1
3
Ex
p
Co
n
Ex
p
Co
n
Ex
p
Co
n
Ex
p
Co
n
Ex
p
Co
n
Ex
p 
m
in
u
s 
co
n
Ex
p 
m
in
u
s 
co
n
VA
S 
wa
lk
in
g 
(cm
)
Pa
rti
ci
pa
nt
 
ra
te
d
5.
0 
(2.
2) 
n
 =
 2
5
6.
5 
(2.
1) 
n
 =
 1
9
5.
6 
(1.
3) 
n
 =
 2
1
6.
6 
(1.
1) 
n
 =
 1
7
5.
5 
(2.
1) 
n
 =
 1
7
6.
9 
(1.
7) 
n
 =
 1
3
45
 (1
02
) 
n
 =
 2
1
6 
(43
) 
n
 =
 1
6
36
 (1
16
) 
n
 =
 1
7
9 
(40
) 
n
 =
 1
3
35
 
(–1
1 
to
 8
0)
21
 
(–2
5 
to
 6
8)
Th
er
a
pi
st
 
ra
te
d
6.
0 
(2.
1) 
n
 =
 2
5
7.
2 
(1.
8) 
n
 =
 2
1
6.
1 
(1.
7) 
n
 =
 2
1
7.
5 
(1.
0) 
n
 =
 1
6
6.
4 
(2.
4) 
n
 =
 1
7
7.
8 
(0.
7) 
n
 =
 1
3
22
 
(63
) 
n
 =
 2
1 
3 
(24
) 
n
 =
 1
6 
19
 
(39
) 
n
 =
 1
7 
5 
(28
) 
n
 =
 1
4
19
 
(–1
0 
to
 4
7)
2 
(–1
9 
to
 2
3)
Ti
m
e
d 
Up
 a
n
d 
G
o
 
te
st
 
(se
c)
14
.
6 
(9.
6) 
n
 =
 2
5
15
.
7 
(16
.
5) 
n
 =
 2
1
13
.
1 
(10
.
6) 
n
 =
 2
2
12
.3
 
(6.
6) 
n
 =
 1
8
18
.
1 
(31
.
6) 
n
 =
 1
9
9.
5 
(1.
5) 
n
 =
 1
5
–
11
 (1
8) 
n
 =
 2
2
–
5 
(20
) 
n
 =
 1
8 
2 
(51
) 
n
 =
 1
9
–
18
 (2
0) 
n
 =
 1
6 
–
5 
(–1
7 
to
 7
)
19
 
(–5
 to
 4
3)
10
 
m
 W
a
lk
 
te
st
 
(se
c)
10
.
3 
(3.
6) 
n
 =
 1
7
11
.
0 
(5.
1) 
n
 =
 1
3
10
.
0 
(6.
3) 
n
 =
 1
4
9.
5 
(3.
8) 
n
 =
 1
1
11
.
8 
(12
.6
) 
n
 =
 1
5
8.
3 
(1.
5) 
n
 =
 1
1
–
4 
(23
) 
n
 =
 1
4
–
7 
(8)
 
n
 =
 1
1
10
 
(57
) 
n
 =
 1
3
–
11
 
(6)
 
n
 =
 8
3 
(–1
0 
to
 1
5)
20
 
(–1
0 
to
 4
9)
Sh
a
de
d 
ro
w
 =
 p
rim
a
ry
 o
u
tc
o
m
e
 m
e
a
su
re
. 
 E
xp
 =
 e
xp
e
rim
e
n
ta
l g
ro
u
p,
 
Co
n
 =
 c
o
n
tro
l g
ro
u
p,
 
G
EE
 =
 g
e
n
e
ra
lis
e
d 
es
tim
a
tin
g 
eq
u
a
tio
n
s,
 
VA
S 
=
 
vi
su
al
 
a
n
a
lo
gu
e 
sc
a
le
5B
CM
F

M
e
a
n
 (S
D)
 of
 gr
o
u
ps
,
 
pe
rc
e
n
ta
ge
 c
ha
n
ge
 (S
D)
 fro
m
 b
a
se
lin
e,
 
a
n
d 
m
e
a
n
 (9
5%
 C
I) d
iff
e
re
n
ce
 b
e
tw
e
e
n
 g
ro
u
ps
 in
 p
e
rc
e
n
ta
ge
 c
ha
n
ge
 fr
o
m
 b
a
se
lin
e
 
fo
r a
ll 
ou
tc
o
m
e
s,
 
fo
r 
pa
tie
nt
s 
w
ith
 
H
oe
hn
 
a
n
d 
Ya
hr
 
st
a
ge
 
<
 
3 
(su
bg
ro
up
 
a
n
a
lys
is)
.
 
G
en
er
al
is
ed
 
e
st
im
at
in
g 
e
qu
at
io
ns
 
(G
EE
) w
e
re
 
u
se
d 
to
 
e
st
im
at
e
 
ch
a
n
ge
s 
in
 
sc
o
re
s 
fro
m
 
ba
se
lin
e
 
be
tw
e
e
n
 s
u
bje
ct
s 
a
n
d 
o
ve
r 
tim
e
 
a
s 
a
 d
iff
e
re
n
ce
 
in
 
di
ffe
re
n
ce
 
sc
o
re
 in
 
pe
rc
e
n
t.
O
u
tc
o
m
e
G
ro
u
ps
Pe
rc
e
n
ta
ge
 c
ha
n
ge
 fr
o
m
 b
a
se
lin
e
 (S
D)
,
 
e
st
im
a
te
d 
fro
m
 G
EE
D
iff
e
re
n
ce
 
in
 
pe
rc
e
n
ta
ge
 
ch
a
n
ge
 
fro
m
 b
a
se
lin
e
 b
e
tw
e
e
n
 g
ro
u
ps
 
(95
%
 C
I), 
e
st
im
a
te
d 
fro
m
 G
EE
W
e
e
k 
–1
 to
 0
W
e
e
k 
7 
to
 8
W
e
e
k 
12
 to
 1
3
W
e
e
k 
7 
to
 8
W
e
e
k 
12
 to
13
W
e
e
k 
7 
to
 8
W
e
e
k 
12
 to
 1
3
Ex
p
Co
n
Ex
p
Co
n
Ex
p
Co
n
Ex
p
Co
n
Ex
p
Co
n
Ex
p 
m
in
u
s 
co
n
Ex
p 
m
in
u
s 
co
n
VA
S 
wa
lk
in
g 
(cm
)
Pa
rti
ci
pa
nt
 
ra
te
d
5.
0 
(2.
3) 
n
 =
 1
9
6.
9 
(2.
0) 
n
 =
 1
6
5.
7 
(1.
3) 
n
 =
 1
6
6.
6 
(1.
1) 
n
 =
 1
4
5.
4 
(2.
0) 
n
 =
 1
3
6.
9 
(1.
7) 
n
 =
 1
2
53
 (1
16
) 
n
 =
 1
6
–
6 
(31
) 
n
 =
 1
3
45
 (1
33
) 
n
 =
 1
3
–
3 
(29
) 
n
 =
 1
1
52
 
(–2
 to
 1
07
)
33
 
(–2
5 
to
 9
1)
Th
er
a
pi
st
 
ra
te
d
6.
3 
(1.
8) 
n
 =
 1
9
7.
4 
(2.
0) 
n
 =
 1
7
6.
5 
(1.
5) 
n
 =
 1
6
7.
5 
(0.
8) 
n
 =
 1
4
7.
0 
(1.
9) 
n
 =
 1
3
7.
7 
(0.
8) 
n
 =
 1
2
16
 
(54
) 
n
 =
 1
6
0 
(22
) 
n
 =
 1
4
18
 
(36
) 
n
 =
 1
3
3 
(29
) 
n
 =
 1
2
16
 
(–1
2 
to
 4
3)
4 
(–1
9 
to
 2
7)
Ti
m
e
d 
Up
 a
n
d 
G
o
 te
st
 
(se
c)
11
.
4 
(3.
6) 
n
 =
 1
9
11
.
5 
(3.
5) 
n
 =
 1
7
10
.
1 
(2.
4) 
n
 =
 1
7
10
.
5 
(2.
0) 
n
 =
 1
5
10
.
4 
(3.
4) 
n
 =
 1
5
9.
3 
(1.
4) 
n
 =
 1
4
–
8 
(13
) 
n
 =
 1
7
–
3 
(10
) 
n
 =
 1
5
–
7 
(12
) 
n
 =
 1
5
–
12
 
(8)
 
n
 =
 1
4
–
6 
(–1
3 
to
 2
)
6 
(–1
 to
 1
3)
10
 
m
 W
a
lk
 
te
st
 
(se
c)
9.
7 
(2.
6) 
n
 =
 1
2
10
.
5 
(4.
2) 
n
 =
 1
0
8.
1 
(2.
2) 
n
 =
 1
0
8.
8 
(2.
7) 
n
 =
 9
7.
9 
(2.
2) 
n
 =
 1
1
8.
1 
(1.
5) 
n
 =
 1
0
–
12
 (1
0) 
n
 =
 1
0
–
7 
(8)
 
n
 =
 9
–
12
 
(4)
 
n
 =
 9
–
11
 
(6)
 
n
 =
 8
–
5 
(–1
3 
to
 2
)
–
1 
(–6
 to
 3
)
Ex
p 
=
 
ex
pe
rim
en
ta
l g
ro
up
,
 
Co
n 
=
 
co
n
tro
l g
ro
up
,
 
G
EE
 
=
 
ge
n
e
ra
lis
ed
 
e
st
im
at
in
g 
e
qu
at
io
ns
,
 
VA
S 
=
 
vi
su
al
 
a
n
a
lo
gu
e 
sc
a
le
Journal of Physiotherapy 2011  Vol. 57  –  © Australian Physiotherapy Association 2011 33
Discussion
In this study, groups were comparable at baseline, but 
neither the intention-to-treat analysis nor the per-protocol 
analysis revealed any effects of mental practice on walking 
performance by patients with Parkinson’s disease. In the 
subgroup analysis of those participants with Hoehn and 
Yahr stages below 3, the experimental and control groups 
were again comparable at baseline. Although a general 
trend in favour of the mental practice group was revealed, it 
was not statistically signiﬁcant.
Based on our power calculation, the group sizes should 
have been sufﬁcient to reveal differences. Perhaps our 
assumptions were too optimistic or it may have been 
unrealistic to expect an additional therapy incorporated into 
an existing treatment program to have as large an effect as 
we sought. Therefore the group sizes may have been too 
small. However, the study by Tamir and co-workers (2007) 
did reveal signiﬁcant effects on the Timed Up and Go test 
in a smaller research population (n = 23) than our total 
population (n = 47). The research populations were quite 
similar except for severity of the disease. Patients with 
Hoehn and Yahr stages of 3 and higher were included in 
our trial and may have been unable to use the techniques 
adequately, which might have inﬂuenced the results of the 
entire group. Results from the analysis of the subgroup (n = 
36), whose characteristics were almost like those from the 
patients from the other trial, did show a general but non-
signiﬁcant trend in favour of the mental practice group.
In two recent reviews there has been a call for distinction 
between treatments for moderately and severely affected 
patients (Dibble et al 2009, Kwakkel et al 2007). Mental 
practice might well be a treatment suitable only for patients 
in less severe stages of Parkinson’s disease, who are perhaps 
better at applying the technique. Our subgroup analysis and 
the study by Tamir and colleagues suggest that this may 
be the case. This hypothesis is also supported by other 
literature (Sammer et al 2006).
The improvement in both groups in this study was 
remarkable given that the disease is generally progressive, 
and given that all participants had already received therapy 
and were still receiving it. One might speculate that both 
mental practice and relaxation had a beneﬁcial effect, 
especially because both groups had similar amounts of 
treatment and compliance with the new therapies. Because 
both groups improved, maybe the contrast between the 
two interventions was not large enough or the groups were 
too small to detect possible effects. A control group with 
an incorporated therapy was needed, however, to control 
and compensate for additional attention. Apart from the 
study by Tamir and colleagues, relaxation has been part 
of the control intervention in other studies (Kamsma et al 
1995) with signiﬁcant effects in favour of the experimental 
treatment. However, there is also some evidence that 
relaxation as part of a treatment package might help 
patients with Parkinson’s disease (Kwakkel et al 2007), but 
at this point there is no evidence that relaxation as a single 
intervention improves locomotor tasks like walking. Effects 
of both mental practice and relaxation in this study could 
only have been revealed with a third, regular-therapy-only 
group, but this was not incorporated.
Participants in this trial may not have practised enough 
under the supervision of a physiotherapist. We taught 
the participants mental practice for a total of six hours, 
whereas a total of 12 hours was used in the study by Tamir 
and colleagues. Partly this was compensated for by the 
unsupervised imagery in our study. As all participants were 
community-dwelling people, we assumed that they would 
be able to ﬁll in the patient-completed logs correctly after 
receiving instruction, although this was not assessed. It is 
difﬁcult to know to what extent the mental practice therapy 
was actually used by the participants at home. Some 
participants reported an additional 15 hours of unguided 
mental practice, but the average of 3 hours and 50 minutes 
might still have been too small because some participants 
did not practise unsupervised at all. On the other hand, if 
the variation in dose was an important factor in this study, 
the per-protocol analysis should have revealed a beneﬁt in 
compliant participants, but it did not.
More objective measures could have been used to select 
patients whose cognitive abilities might allow them to better 
engage in mental practice (other than the Mini-Mental State 
Examination, which was not developed to evaluate imagery 
ability). Recently ways of measuring the imagery ability, 
like the hand-rotation test and the Kinaesthetic and Visual 
Imagery Questionnaire (Malouin et al 2007, Simmons et 
al 2008), have been introduced. At this point, however, 
it is not known if being able to perform mental imagery 
necessarily equates to beneﬁting from it in clinical practice. 
In addition, we do not know if people who are unable to 
perform imagery at baseline are able to learn to do so.
In this study, we did not ﬁnd differences between embedded 
mental practice and current standard of care with relaxation. 
The working mechanisms for mental practice interventions 
in Parkinson’s disease are based on evidence from sports 
and fundamental clinical research performed over the last 
10 years in patients with different pathologies, mainly 
stroke (Dickstein and Deutsch 2007, Feltz and Landers 
1988). Since mental practice is a relatively new treatment 
in patients with Parkinson’s disease, it seems important to 
adjust and develop the intervention to the speciﬁcs of this 
population and the individual abilities (Craig et al 2008). 
Further research is needed to study underlying mechanisms 
of why mental practice works in some patients and does not 
in others. The mental practice intervention should be tested 
to determine the optimal content and dose. Q
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